Enhancement of chicken resistance against Escherichia coli infection by oral administration of Bifidobacterium thermophilum preparations

Avian Diseases

Volumn 46, Issue 3, 2002, Pages 542-546

  Kobayashi, Chizu ^a   Yokoyama, Hideaki ^a   Nguyen, Sa V ^a   Hashi, Tomomi ^a   Kuroki, Masahiko ^a   Kodama, Yoshikatsu ^a  

^a GHEN Corporation   (Japan)

Author keywords

Bifidobacterium thermophilum; Chicken; Escherichia coli; Lymphocyte proliferation

Indexed keywords

ANIMALIA; AVES; BIFIDOBACTERIUM; BIFIDOBACTERIUM THERMOPHILUM; ENTEROBACTER; ESCHERICHIA COLI; GALLUS GALLUS;

EID: 0036656186     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/0005-2086(2002)046[0542:EOCRAE]2.0.CO;2     Document Type: Article

References (15)

1. Isolauri, E., J. Joensuu, H. Suomalainen, M. Luomala, and T. Vesikali. Improved immunogenicity of oral xRRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13:310-312. 1995.
2. Namba, Y., Y. Hidaka, and K. Taki. Effect of oral administration of lysozyme or digested bacterial cell walls on immunostimulation in guinea pigs. Infect. Immun. 31:580-583. 1981.
3. Namioka, S., T. Sasaki, and Y. Maeda. Immunopotentiation of the small intestine of weaning piglets by peptidoglycan derived from Bifidobacterium thermophilum. Bifidobacteria Microflora 10:1-9. 1991.
4. Namioka, S., Y. Kumeda, and T. Kawamoto. The influence of immunopotentiation on suckling piglets with special reference to the incidence of pig scour. Br. Vet. J. 138:155-167. 1982.
5. Owen, R. L. Uptake and transport of intestinal macromolecules and microorganisms by M cells in Peyer's patches - a personal and historical perspective. Immunology 11:157-163. 1999.
6. Piercy, D. W. T., and B. West. Experimental Escherichia coli infection in broiler chickens: course of the disease induced by inoculation via the air sac route. J. Comp. Pathol. 86:203-210. 1976.
7. Sasaki, T., S. Fukami, and S. Namioka. Enhanced cytotoxic activity of lymphocytes in mice by oral administration of peptidoglycan (PG) derived from Bifidobacterium thermophilum. J. Vet. Med. Sci. 56:1129-1133. 1994.
8. Sasaki, T., S. Fukami, and S. Namioka. Enhanced resistance of mice to Escherichia coli infection induced by administration of peptidoglycan derived from Bifidobacterium thermophilum. J. Vet. Med. Sci. 56:433-437. 1994.
9. Sasaki, T., Y. Maeda, and S. Namioka. Immunopotentiation of the mucosa of the small intestine of weaning piglets by peptidoglycan. Jpn. J. Vet. Sci. 49:235-243. 1987.
10. Sasaki, T., Y. Samegai, and S. Namioka. Phagocytosis of splenetic neutrophils of mice enhanced by oral administration of peptidoglycan from Bifidobacterium thermophilum. J. Vet. Med. Sci. 58: 85-86. 1996.
11. Suzuki, T., K. Itoh, T. Kaneko, and H. Suzuki. Inhibition of bacterial translocation from the gastrointestinal tract of mice by oral administration of a culture condensate of Bifidobacterium longum. J. Vet. Med. Sci. 59:665-669. 1997.
12. Yasui, H., J. Kiyoshima, T. Hori, and K. Shida. Protection against influenza virus infection of mice fed with Bifidobacterium breve YIT 4064. Clin. Diagn. Lab. Immunol. 6:186-192. 1999.
13. Yasui, H., J. Kiyoshima, and H. Ushijima. Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed with Bifidobacterium breve YIT 4064. J. Infect. Dis. 172: 403-409. 1995.
14. Yasui, H., N. Nagaoka, and K. Hayakawa. Augmentation of anti-influenza virus hemmagglutinin antibody production by Payer's patch cells with Bifidobacterium breve YIT 4064. Clin. Diagn. Lab. Immunol. 1:244-246. 1994.
15. Yasui, H., N. Nagaoka, K. Mike, K. Hayakawa, and M. Ohwaki. Detection of Bifidobacterium strains that induce large quantities of IgA. Microb. Ecol. Health Dis. 5:155-162. 1992.